Human OKT3 scFv Stable Cell Line - CHO-K1

The Human OKT3 scFv Stable Cell Line - CHO-K1 is a recombinant mammalian cell line generated by stably transfecting the OKT3 single-chain variable fragment (scFv) gene into the CHO-K1 host cell background. OKT3 is a well-characterized murine monoclonal antibody that specifically recognizes the CD3 epsilon chain of the human T-cell receptor complex. The OKT3 scFv retains the antigen-binding specificity of the full-length antibody while offering advantages in size, tissue penetration, and ease of genetic manipulation. This stable cell line continuously expresses the human OKT3 scFv, which can be secreted into the culture supernatant or purified for downstream applications. The CHO-K1 platform is widely used for recombinant protein expression due to its robust growth characteristics, high transfection efficiency, and ability to perform proper post-translational modifications. The cell line is typically generated through lentiviral or plasmid-based transfection followed by antibiotic selection and single-cell cloning to ensure stable and homogeneous expression.

This stable cell line serves as a valuable tool for a range of research and development applications. It is particularly useful in the field of CAR-T cell therapy, where the OKT3 scFv is commonly employed as a surface marker for detecting CAR expression using anti-CD3 antibodies. Researchers can use the purified OKT3 scFv protein as a positive control in ELISA, Western blot, and flow cytometry assays designed to evaluate CAR-T cell binding and functionality. The cell line also supports early-stage drug discovery by providing a consistent and reproducible source of the OKT3 scFv for binding studies, epitope mapping, and competition assays. Additionally, the secreted scFv can be used to coat beads or plates for T-cell activation and expansion experiments, as the OKT3 scFv retains the ability to crosslink CD3 receptors and stimulate T-cell proliferation. The stable nature of the expression system ensures lot-to-lot consistency, reducing experimental variability and making it suitable for both academic research and industrial-scale bioprocess development.